Lung cancer remains one of the most prevalent and challenging forms of cancer worldwide. However, advancements in medical science have led to a variety of treatment options that offer hope and improved outcomes for patients. In this blog, our lung cancer specialists in Surat at BCI- Blood and Cancer Institute, have shared four primary treatment modalities for lung cancer: surgery, chemotherapy, radiation therapy, and targeted therapy, highlighting their effectiveness and role in combating this disease.

1. Chemotherapy:

Chemotherapy involves the use of powerful drugs to kill cancer cells or inhibit their growth. Cancer specialists in Surat often use it in combination with other treatments, such as surgery or radiation therapy, to target cancer cells throughout the body. Chemotherapy may be administered orally or intravenously and is typically given in cycles to allow the body time to recover between treatments. While chemotherapy can cause side effects such as nausea, hair loss, and fatigue, advances in medical science have led to the development of more targeted and tolerable chemotherapy regimens for lung cancer patients.

2. Radiation Therapy:

Radiation therapy utilizes high-energy rays to destroy cancer cells and shrink tumours. It is often employed as a primary treatment for localized lung cancer or as adjuvant therapy following surgery to eliminate any remaining cancer cells. Radiation therapy may be delivered externally (external beam radiation) or internally (brachytherapy), depending on the size and location of the tumour. At Blood and Cancer Institute (BCI), one of the best cancer hospitals in Surat, experts recommend modern techniques such as intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT) for precise targeting of the tumour while sparing surrounding healthy tissue, reducing side effects and improving outcomes for patients.

3. Targeted Therapy:

Targeted therapy is a form of treatment that specifically targets cancer cells while minimizing damage to healthy cells. It works by identifying and attacking specific molecules or pathways involved in cancer growth and proliferation. In the case of lung cancer, targeted therapy may be directed at genetic mutations such as EGFR (epidermal growth factor receptor) mutations or ALK (anaplastic lymphoma kinase) rearrangements. Drugs known as tyrosine kinase inhibitors (TKIs) are commonly used in targeted therapy for lung cancer and have been shown to be highly effective, particularly in patients with advanced or metastatic disease.

4.Surgery:

Surgery plays a crucial role in the treatment of lung cancer, particularly in the early stages when the tumour is localized and has not spread beyond the lungs. The goal of surgery is to remove the cancerous tissue and, if possible, any nearby lymph nodes where cancer may have spread. Depending on the size and location of the tumour, different surgical approaches may be employed, including:

- Lobectomy: Removal of an entire lobe of the lung.

- Wedge resection: Removal of a small section of the lung.

- Pneumonectomy: Removal of an entire lung.

Surgical techniques have evolved significantly, with minimally invasive procedures such as video-assisted thoracic surgery (VATS) and robotic-assisted surgery offering shorter recovery times and reduced postoperative discomfort for patients.

Targeted therapy as part of cancer treatment in Surat offers several advantages over traditional chemotherapy, including:

- Higher response rates.

- Fewer side effects.

- Prolonged progression-free survival.

- Improved quality of life.

- The potential for oral administration, increasing convenience for patients.

Conclusion

The treatment landscape for lung cancer has evolved significantly in recent years, offering patients a range of effective options tailored to their individual needs. Surgery, chemotherapy, radiation therapy, and targeted therapy each play a crucial role in combating this disease, either alone or in combination. With ongoing research and advancements in medical science, the future holds promise for further improving outcomes and quality of life for lung cancer patients around the world.